Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CrossWing is a privately held Canadian robotics and artificial intelligence company developing interactive personal robotics systems for healthcare, security, telepresence, in-home support, and related markets. Its core technology appears to be the nav2 modular robotics platform, which the company describes as a customizable foundation for multiple robot products built on a common hardware and software base. CrossWing markets products including Cleanbot for autonomous cleaning and UV-C disinfection use cases and Bishop for security and emergency-response oriented applications. While the company has healthcare-adjacent positioning, especially around assistive care, health monitoring, and facility disinfection, it does not appear to be a biotechnology or pharmaceutical developer. The business is better characterized as a commercial robotics platform company serving healthcare and other verticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CrossWing.